Form4insider filings, from the source

SEC Form 3 · accession 0000899243-19-000006

Zymeworks Inc. · ZYME

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Ali Tehrani
Officer — Chief Executive Officer · Director
Period of report
Jan 1, 2019
Accepted (ET)
Jan 2, 2019 · 6:38 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001403752

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Sharesholding———256,009D
Common Sharesholding———62,286IHeld by spouse

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2,F1$5.37holding———Jan 1, 2013Jan 1, 2022Common Shares58,660—D
Stock Option (Right to Buy)F2,F1$7.26holding———Jan 1, 2014Jan 1, 2023Common Shares20,950—D
Stock Option (Right to Buy)F2,F1$11.60holding———Jan 1, 2015Jan 1, 2024Common Shares20,950—D
Stock Option (Right to Buy)F2,F1$14.44holding———Jan 1, 2016Jan 1, 2025Common Shares23,464—D
Stock Option (Right to Buy)F2,F1$12.10holding———Jan 29, 2017Jan 29, 2026Common Shares293,300—D
Stock Option (Right to Buy)F2,F1$22.60holding———Feb 3, 2018Feb 3, 2027Common Shares41,900—D
Stock Option (Right to Buy)F1$9.82holding———Jun 12, 2018Jun 12, 2027Common Shares250,000—D
Stock Option (Right to Buy)F1$11.84holding———Mar 19, 2019Mar 18, 2028Common Shares250,000—D

Explanation of responses

Remarks

Exhibit List - Exhibit 24 - Power of Attorney